WuXi Biologics is a contract research, development and manufacturing organisation serving the biopharmaceutical industry. The company helps drug developers discover, develop and manufacture biologic medicines, including antibody-based therapies, from its base in China for customers around the world. Its services span early-stage research through clinical and commercial production, and it works with both small biotech firms and larger pharmaceutical companies that need external development and manufacturing capacity for their biologic candidates.
On this site WuXi Biologics appears as a stock on the Hong Kong Stock Exchange (Hong Kong), code 2269, with prices in Hong Kong dollars (HKD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Strong price profile
Ranks #22 of 3157 on the Hong Kong Stock Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Hong Kong yet.
TrendStrong
89/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average22.6%
From 52-week high-16.8%
MomentumStrong
85/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return26.0%
6-month return29.6%
12-month, skipping last month18.9%
Stability (higher is calmer)Strong
73/100
Calmer than most: low volatility and shallow drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)45.3%
Worst drawdown, 1 year (smaller is calmer)-28.7%
LiquidityStrong
100/100
Trades actively.
See the numbers →
Avg daily value traded1,752.34M HKD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Hong Kong when fundamentals data for this market is added. All Hong Kong stocks.
52-wk range 28.48 – 58.00Daily closes, split-adjusted
Signals
50-day average50.34
200-day average39.32
Golden/death cross (60d)Golden, 51 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)2.54
Technical summary
Daily
Neutral
8 bullish · 1 neutral · 7 bearish
Weekly
Strongly bullish
9 bullish · 1 neutral · 2 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
52.84
Bearish
EMA 10
51.43
Bearish
SMA 20
52.98
Bearish
EMA 20
51.86
Bearish
SMA 50
50.34
Bearish
EMA 50
49.38
Bearish
SMA 100
42.86
Bullish
EMA 100
45.31
Bullish
SMA 200
39.32
Bullish
EMA 200
40.80
Bullish
Oscillators (daily)
RSI (14)
38.77
Neutral
MACD (12, 26)
0.12
Bullish
Momentum (12)
-9.91
Bearish
Stochastic %K (14)
19.54
Bullish
Williams %R (14)
-80.46
Bullish
CCI (20)
-176.4
Bullish
Pivot points (classic, last session)
S3
40.70
S2
43.26
S1
45.73
Pivot
48.29
R1
50.76
R2
53.32
R3
55.79
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in HKD. Educational only, not financial advice.
